There is no such thing as a mild MS relapse. The mild relapse is an Anglo-Saxon delusion - Yes

Multiple Sclerosis Journal

Volumn 18, Issue 7, 2012, Pages 927-929

  Edan, Gilles ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISABILITY; DISABILITY INDEX; DISEASE COURSE; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; HUMAN; MULTIPLE SCLEROSIS; NERVE DEGENERATION; PHENOTYPE; RATING SCALE; RECURRENT DISEASE; SCORING SYSTEM;

EID: 84863219962     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512450090     Document Type: Article

References (15)

1. Frischer J, Brasmow S, Lucchinetti C, Raushka H, Schimdbauer M, Laursen H, et al. The relationship between inflammation and neurodegeneration in multiple sclerosis. Brain 2009; 132: 1175-1189.
2. Confavreux C, Vukusic S, Moreau T and Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-1438.
3. Confavreux C, Vukusic S and Adeleine P. Early clinical predictors and progression of irreversible disability: an amnesic process. Brain 2003; 126: 770-782. (Pubitemid 36372978)
4. Confavreux C and Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006; 129: 606-616. (Pubitemid 43278223)
5. Weinshenker BG, Bass B, Rice GP, Noseworthy JH, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146. (Pubitemid 19056478)
6. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM and Ebers GC. The natural history of multiple sclerosis: a geographically bases study. 9: Observations on the progressive phase of the disease. Brain 2006; 129: 584-594. (Pubitemid 43278221)
7. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, et al. The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability: Brain 2010: 133; 1914-1929.
8. Scalfari A, Neuhaus A, Daumer M, Ebers GC and Muraro PA. Age and disability accumulation in multiple sclerosis. Neurology 2011; 77: 1246-1252.
9. Lublin FD, Baier M and Cutter G. Effect of relapse on development of residual deficit in multiple sclerosis. Neurology 2003; 61: 1528-1532. (Pubitemid 37505574)
10. Leray E, Yaouanq Y, Le Page E, Coustans M, Laplaud D, Oger J, et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain 2010; 133: 1900-1913.
11. Tremlett H, Paty D and Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology 2006; 66: 172-177. (Pubitemid 43970148)
12. Tremlett H, Yousefi M, Devonshire V, Rieckmann P and Zhao Y. Impact of multiple sclerosis relapses on progression diminishes with time. Neurology 2009; 73: 1616-1623.
13. Li DK, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F, et al. MRI T2 lesion burden in multiple sclerosis: A plateauing relationship with clinical disability. Neurology 2006; 66: 1384-1389. (Pubitemid 43739648)
14. Fisniku LK, Brex PA, Altmann TR, Riskiel KA, Benton CE, Lanyon R, et al. Disability and T2 MRI lesions: a 20 year follow-up of patients with relapse onset of MS. Brain 2008; 131: 808-817. (Pubitemid 351294716)
15. Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 2006; 253: 98-108. (Pubitemid 43157395)